跳至主要内容
临床试验/NCT02804919
NCT02804919已完成不适用

CPAP In-home Assessment NZ

Fisher and Paykel Healthcare2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Apnea Hypopnea Index (AHI), measured as number of events/hour hour.

研究概览

简要总结

Phase 1:The study is to evaluate the product reliability, therapy effectiveness and user feedback of a Continuous Positive Airway Pressure (CPAP) device in-home for up to 6 months.

Phase 2: To evaluate the CPAP device with communication functionality with data upload.

详细描述

Phase 1:Existing and Naïve CPAP users will be recruited into a 6 month in-home study Participants will attend 5 study visits at day 0, 7, 30, 60 and 180. Outcome of the clinical investigation include downloadable device data reports, device error reports and participants perception questionnaires.

Phase 2: 10 participants from Phase 1 will be recruited to use the device for up to 6 month in-home. Participants will attend 3 study visits at day 0, 7 30. The trial may be extended to 60 days if longer term data is required.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 and over
  • Diagnosed with Obstructive Sleep Apnea (OSA) and prescribed Positive Airway Pressure (either Continuous positive airway pressure (CPAP) or AutoCPAP)
  • Be fluent in spoken and written English

排除标准

  • Contraindicated for Positive Airway Pressure (CPAP or AutoCPAP) therapy
  • Persons with other significant sleep disorder(s) (e.g periodic leg movements, insomnia, central sleep apnea)
  • Persons with obesity hypoventilation syndrome or congestive heart failure
  • Persons that require supplemental oxygen with their Positive Airway Pressure (CPAP or AutoCPAP) device.
  • Persons with implanted electronic medical devices (e.g cardiac pacemakers)
  • Persons who are pregnant or think they may be pregnant.

研究组 & 干预措施

Investigational CPAP device

Experimental

Fisher & Paykel Healthcare CPAP Device

干预措施: Fisher & Paykel Healthcare CPAP Device (Device)

结局指标

主要结局

Apnea Hypopnea Index (AHI), measured as number of events/hour hour.

时间窗: 6 months

Obtained from the device - Phase 1 and Phase 2 of the trial

Machine reported faults, measured as number of machine faults

时间窗: 6 months

Obtained from the device - Phase 1 and Phase 2 of the trial

Log of safety-related events, measured as number of safety-related faults

时间窗: 6 months

Obtained from the device - Phase 1 and Phase 2 of the trial

Participant reported faults, measured as number of participant complaints

时间窗: 6 months

Obtained from the follow up visits - Phase 1 and Phase 2 of the trial

次要结局

  • Perception of the device, measured through questionnaire(6 months)

研究者

发起方
Fisher and Paykel Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验